Kymera Therapeutics, Inc.

KYMR · Healthcare · $9.2B

$112.65+0.77%

Price

$113.5

$111.0

Jul 2, 26Oct 1, 26

What's this stock's score right now?

See its score for free — revenue and money flow, graded on one standard.

Quarterly Financials

RevenueOperating IncomeNet Income

9/'26

Revenue$4M-94.1%

6/'26 vs prev quarter

Company Health

Market Cap$9.2B

Operating Margin-333.5%

Cash on Hand$691M7.5% of market cap

Free Cash Flow$-238M-2.6% of market cap

Among 327 Biotechnology peers

LowMedianHigh

PSR87.6xmedian 11.7xPBR6.1xmedian 2.1xROE-19.9%median -54.5%